Short-Chain Fatty Acids Regulate the Enteric Neurons and Control Gastrointestinal Motility in Rats

2010/02/11 by Rodolphe Soret, J. Chevalier, Julien Chevalier +6 · 33 citations
Medicine · #Gastrointestinal motility and disorders #Diet and metabolism studies #Congenital gastrointestinal and neural anomalies

paper · pdf · doi:10.1053/j.gastro.2010.01.053

Cited by

• The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System
• The Microbiota‐Derived Metabolite Deoxycholic Acid Regulates Enteric Neuron Activity and Connectivity
• SCFA: mechanisms and functional importance in the gut
• The Microbiota-Gut-Brain Axis
• Antipsychotic-induced gastrointestinal hypomotility and the alteration in gut microbiota in patients with schizophrenia
• The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system
• Gut microbiome, a potential modulator of neuroepigenome
• Butyrate enemas enhance both cholinergic and nitrergic phenotype of myenteric neurons and neuromuscular transmission in newborn rat colon
• Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. [europepmc]
• Consumption of fermented milk product with probiotic modulates brain activity. [europepmc]
• A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids. [europepmc]
• Specialized metabolites from the microbiome in health and disease. [europepmc]
• Gut chemosensing mechanisms. [europepmc]
• Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. [europepmc]
• Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. [europepmc]
• Microbiome therapeutics - Advances and challenges. [europepmc]
• Irritable bowel syndrome: a gut microbiota-related disorder? [europepmc]
• Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients. [europepmc]
• The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. [europepmc]
• The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? [europepmc]
• Butyrate: A Double-Edged Sword for Health? [europepmc]
• Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion. [europepmc]
• Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome. [europepmc]
• The Human Gut Microbiome - A Potential Controller of Wellness and Disease. [europepmc]
• Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease. [europepmc]
• Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. [europepmc]
• Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease. [europepmc]
• Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. [europepmc]
• Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. [europepmc]
• Advancing human gut microbiota research by considering gut transit time. [europepmc]
• Gut microbiome-wide association study of depressive symptoms. [europepmc]
• Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications. [europepmc]
• The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease. [europepmc]